Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.

× No keyword cloud information.

23 in total

Review 1. Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.

Authors: M T Roe; D J Moliterno
Journal: J Thromb Thrombolysis Date: 1999-06 Impact factor: 2.300

Review 2. Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients.

Authors: K H Mak; M B Effron; D J Moliterno
Journal: Drugs Aging Date: 2000-03 Impact factor: 3.923

Review 3. Update in internal medicine.

Authors: F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal: Arch Med Res Date: 2000 Jul-Aug Impact factor: 2.235

4. Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond.

Authors: G Manoharan; A A Adgey
Journal: Heart Date: 2001-09 Impact factor: 5.994

5. New advances in the management of acute coronary syndromes.

Authors: P W Armstrong
Journal: CMAJ Date: 2001-05-01 Impact factor: 8.262

Review 6. Glycoprotein receptor inhibitors in the management of acute coronary syndromes.

Authors: Henock Saint-Jacques; And Robert A Harrington
Journal: Curr Cardiol Rep Date: 2002-07 Impact factor: 2.931

Review 7. Glycoprotein IIb/IIIa receptor antagonists in the treatment of acute ST elevation MI: from hypotheses to unexpected recent observations.

Authors: Allan M Ross
Journal: J Thromb Thrombolysis Date: 2003-04 Impact factor: 2.300

Review 8. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?

Authors: Uwe Zeymer
Journal: J Thromb Thrombolysis Date: 2003-04 Impact factor: 2.300

Review 9. Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Authors: Joseph M Sweeny; Diana A Gorog; Valentin Fuster
Journal: Nat Rev Cardiol Date: 2009-04 Impact factor: 32.419

10. Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.

Authors: Gjin Ndrepepa; Julinda Mehilli; Markus Schwaiger; Stephan Nekolla; Claus Schmitt; Josef Dirschinger; Albert Schömig; Adnan Kastrati
Journal: J Thromb Thrombolysis Date: 2004-06 Impact factor: 2.300